STI stirling products limited

boots trial should be close to completion

  1. 3,448 Posts.
    lightbulb Created with Sketch. 809
    The original announcement for the Boots Clinic trials utilizing 6 Telemedcare units was forecast to continue for another 2 months from announcement on 13th August, that would mean mid October they may be in a position to make a call on the success of the trial and potential broader rollout.

    May line up nicely with the plant approval / commencement of operations and commencement of Stirling Branded Product sales in Australia

    Original Market Release below:

    TeleMedCare Pilot in Pharmacy
    Chain Specialist Health Clinics
    13 August 2010
    Pharmaceutical and Healthcare group, Stirling Products Limited (ASX:STI) advises that a
    significant pilot of specialist Health Clinics within two flagship stores of one of the largest
    pharmacy chains in the UK is underway using the market-leading clinical grade vital signs
    TeleMedCare telemedicine units.
    This pilot phase will assess the effectiveness and benefits of the multi-awarded TeleMedCare
    units from a client, clinical & commercial perspective and if successful, would be expected to be
    incorporated in a major UK national roll-out of specialist Health Clinics within many of the UK
    pharmacies which represent the majority of their over 4,000 pharmacies in the UK and
    internationally.
    Six TeleMedCare fully interactive monitoring and diagnostic units have been purchased for the
    pilot operation, which will continue to be conducted for a further approximate two months.
    Following completion of the pilot and if deemed successful, formal roll-out agreement would be
    expected which the parties would then jointly announce.
    The Company will keep the market advised with regard to any further material developments of
    the pilot and ultimately its outcome.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.